The EPOCH-R clinical trial in Burkitt’s lymphoma

Jeremy Abramson, MD, from the Massachusetts General Hospital, Massachusetts, MA gives an overview of the preliminary data being presented at the American Society of Hematology (ASH) 2015 Annual Meeting in Orlando, FL, on the results of the multi-centre prospective Phase II study of Dose-Adjusted EPOCH-R for Burkitt Lymphoma.